You are here

Article info

Article menu

Download PDFPDF

Systems Biology and Novel Technologies For Molecular Analysis and Diagnosis
P1.31 The costs of targeted ciprofloxacin therapy vs. empiric therapy for neisseria gonorrhoeae infections over a thirteen-month study period
Free

Authors

Citation

Allan-Blitz L, Hemarajata P, Humphries RM, et al
P1.31 The costs of targeted ciprofloxacin therapy vs. empiric therapy for neisseria gonorrhoeae infections over a thirteen-month study period
Sexually Transmitted Infections 2017;93:A56.

Publication history

  • First published July 8, 2017.
Online issue publication 
September 18, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions